INDV Supernus, Inc.

INDV financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1625297 Exchange: Nasdaq SIC: 2834 (Pharmaceutical Preparations) Latest filing: 10-Q filed Oct 29, 2026 Data checked: Nov 10, 2026
Showing 3 of 4 annual and 0 of 10 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$1.83B (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
DE
Fiscal Year End
December (1231)
Phone
804-379-1090
EIN
412520873
Headquarters
ROCKVILLE, MD, 20850
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Indivior Pharmaceuticals, Inc. (2026–2026) · INDIVIOR PLC (2014–2026)

▼ Key Metrics (TTM)

As of Sep 30, 2026
Financials
Revenue
$1.37B
Net Income
$451.00M
Total Assets
$1.33B
Total Equity
$-60.00M
Total Debt
$488.00M
Free Cash Flow
$31.00M
Ratios
Gross Margin
85.1%
Operating Margin
40.6%
Net Margin
32.8%
Return on Equity
-751.7%
Return on Assets
33.9%
Current Ratio
0.61x
Debt / Equity
-8.13x
FCF / Assets
2.3%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, Supernus, Inc. recorded $1.24B of revenue, net income of $210.00M, and an operating cash outflow of $27.00M. The $1.24B revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Compared with $1.19B in fiscal 2024, revenue recorded a 4.3% year-over-year increase. The company reported diluted EPS of $1.64, adding a shareholder-level measure to the absolute income figures considered below. At period end, total assets were $1.20B, framing the scale of the company’s operating and financing commitments. The revenue-to-assets relationship was 1.03x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

After reported cost of revenue, the company retained $994.00M as gross profit before recognizing operating expenses and other items. Gross margin was 80.2%, so that share of each revenue unit remained after the cost of revenue reported for the period. The reported operating result was $262.00M, capturing profitability after direct costs and the operating expenses reflected in the statements. Operating margin measured 21.1%, showing the portion of revenue preserved after the full set of operating costs. The bottom-line result was net income of $210.00M, after the operating, financing, tax, and other items recognized for the period. Net margin was 16.9%, meaning that this portion of revenue remained as net income after all recognized expenses. Before income taxes, the company reported $239.00M of earnings, providing a bridge between the operating result and final net income. Pretax income represented 19.3% of revenue, placing earnings before tax in the context of the company’s operating scale. The reported income-tax provision was $29.00M, the amount recognized between pretax income and the final net-income result. The income-tax provision equaled 12.1% of pretax income, showing the tax burden absorbed by the year’s earnings. The net-income-to-assets relationship measured 17.5%, showing earnings relative to the full balance sheet.

Liquidity and Capital Structure

At period end, the $1.20B asset base was financed through $1.30B of liabilities and -$98.00M of equity. With total equity at -$98.00M, the company carried a negative book-capital position, increasing its reliance on liabilities and future earnings. The near-term balance sheet paired $652.00M of current assets with $914.00M of current liabilities at the reporting date. The current ratio was 0.71x; current liabilities exceeded current assets, leaving a short-term liquidity deficit. The company held $195.00M in cash and equivalents, a narrower liquidity measure than total current assets. The cash balance equaled 21.3% of current liabilities, showing how much near-term coverage came from cash alone. Borrowings totaled $319.00M, adding a fixed financing obligation alongside the company’s equity capital. Relative to total assets, debt measured 26.6%, showing how much of the asset base was matched by borrowing. The liabilities-to-assets relationship was 108.2%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 16.2%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $1.32B in fiscal 2024, the current asset base moved 8.7% and finished lower. Cash and equivalents were 38.9% lower than fiscal 2024 cash of $319.00M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $27.00M, rather than cash generation from operations. Capital spending of $66.00M added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. Operating cash flow and capital spending combined to leave a $93.00M cash deficit after capital spending. Relative to revenue, the post-investment cash deficit represented 7.5%. The free-cash-flow deficit equaled 7.7% of total assets, placing the cash shortfall against the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Supernus, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $1.24B $1.19B $1.09B
Cost of Revenue $246.00M $231.00M $174.00M
Gross Profit $994.00M $957.00M $919.00M
OPERATING EXPENSES
R&D Expense $97.00M $107.00M $116.00M
SG&A Expense $634.00M $612.00M $565.00M
Other Operating Expenses (derived) $1.00M $200.00M $390.00M
Operating Income $262.00M $38.00M $-152.00M
NON-OPERATING INCOME / EXPENSE
Interest Expense $38.00M $30.00M $27.00M
Interest Income $22.00M $23.00M $43.00M
Pretax Income $239.00M $20.00M $-145.00M
Income Tax $29.00M $13.00M $-19.00M
Net Income $210.00M $7.00M $-126.00M
PER SHARE & SUPPLEMENTAL
Diluted EPS $1.64 $0.05 $-0.92
Diluted Shares 128.00M 133.00M 137.00M
EBITDA $272.00M $54.00M $-137.00M
Depreciation & Amortization $10.00M $16.00M $15.00M
Balance Sheet
ASSETS
Cash & Equivalents $195.00M $319.00M $316.00M
Short-term Investments $0 $1.00M $94.00M
Accounts Receivable $253.00M $254.00M $254.00M
Inventory $153.00M $167.00M $135.00M
Other Current Assets $16.00M $21.00M $52.00M
Current Assets $652.00M $827.00M $1.27B
PP&E (Net) $144.00M $100.00M $84.00M
Goodwill $2.00M $2.00M $5.00M
Other Noncurrent Assets $27.00M $39.00M $28.00M
Noncurrent Assets $549.00M $489.00M $494.00M
Total Assets $1.20B $1.32B $1.76B
LIABILITIES
Accounts Payable $48.00M $63.00M $39.00M
Short-term Debt $29.00M $18.00M $3.00M
Other Current Liabilities $0 $11.00M $40.00M
Current Liabilities $914.00M $924.00M $1.29B
Long-term Debt $290.00M $315.00M $237.00M
Other Noncurrent Liabilities $21.00M $18.00M $31.00M
Noncurrent Liabilities $386.00M $728.00M $661.00M
Total Liabilities $1.30B $1.65B $1.95B
EQUITY
Common Stock $62.00M $62.00M $68.00M
Additional Paid-in Capital $112.00M $90.00M $88.00M
Retained Earnings $-243.00M $-443.00M $-295.00M
Accumulated OCI $-30.00M $-36.00M $-30.00M
Total Equity $-98.00M $-337.00M $-191.00M
Total Liabilities & Equity $1.20B $1.32B $1.76B
SUPPLEMENTAL
Total Debt $319.00M $333.00M $240.00M
Check: A − (L + E + Temp. Equity) -† -† -
Cash Flow Statement
Cash from Operations $-27.00M $36.00M $-300.00M
Capital Expenditures $66.00M $29.00M $8.00M
Cash from Investing $-66.00M $69.00M $-95.00M
Cash from Financing $-30.00M $-102.00M $-64.00M
Free Cash Flow $-93.00M $7.00M $-308.00M
Beginning Cash (CFS) $319.00M $316.00M $774.00M
Net Change in Cash $-123.00M $3.00M $-459.00M
Effect of FX on Cash $-1.00M $0 $1.00M
Calculated Ending Cash $195.00M $319.00M $316.00M
Cash per BS $195.00M $319.00M $316.00M
Cash scope difference (CFS − BS) - - -
Cash per CFS $195.00M $319.00M $316.00M

† Balance check within the company's reporting rounding: FY 2025 ($1,000,000), FY 2024 ($1,000,000). The statements are reported rounded to that unit, so their totals can differ from the sum of the lines by up to that amount.

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Supernus, Inc.'s annual revenue?

Supernus, Inc. reported $1.37B in revenue for trailing twelve months (ending September 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Supernus, Inc. profitable?

Yes. Supernus, Inc. reported $451.00M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is Supernus, Inc.'s debt level?

Supernus, Inc. carries $488.00M in total debt as of trailing twelve months. Total shareholders' equity stands at $-60.00M.

Does Supernus, Inc. generate free cash flow?

Yes. Free cash flow was $31.00M for trailing twelve months. Operating cash flow was $96.00M.